QuadMedicine, Inc. (KOSDAQ:464490)
South Korea
· Delayed Price · Currency is KRW 16,220
+320 (2.01%)
At close: Mar 6, 2026
QuadMedicine Company Description
QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP).
The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B.
The company focuses on technology integration for medical and pharmaceutical microneedle development.
It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporated in 2016 and is headquartered in Seongnam-si, South Korea.
QuadMedicine, Inc.
| Country | South Korea |
| Founded | 2016 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Seung-Ki Baek |
Contact Details
Address: Suite 605 Seongnam-si, 13209 South Korea | |
| Phone | 82 3 1754 1152 |
| Website | quadmedicine.com |
Stock Details
| Ticker Symbol | 464490 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Seung-Ki Baek | Chief Executive Officer |
| Young-heung Kim | Chief Financial Officer |